Compare Johnson & Johnson (JNJ) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? Johnson & Johnson trades at $260.78 (market cap $626.09B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $30.8. The key difference: Johnson & Johnson pays a 2.06% dividend while Direxion Daily 20 Year Treasury Bull 3X Shares pays none, and Johnson & Johnson is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| JNJ | TMF | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $267.24 | $44.14 |
52-Week Low | $174.16 | $30.59 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
TMF, a leveraged ETF tracking long-term Treasury bonds, trades at $30.72 with a slight 0.26% daily gain. Technical indicators are predominantly bearish, with moving averages signaling sell pressure and oscillators neutral. The stock faces resistance and support near $31. Recent news highlights significant long-term losses due to leverage decay, emphasizing its high-risk nature.
The outlook for TMF remains speculative, driven by interest rate volatility. Opportunities exist for short-term traders betting on bond market rebounds, but risks include daily leverage reset losses and macroeconomic sensitivity. Investors should treat it as a tactical tool, not a long-term hold, given its erosion of value over time.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
